CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 2 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,215 | +1477.9% | 254,231 | +1296.0% | 0.00% | – |
| Q2 2023 | $77 | -85.7% | 18,211 | -82.0% | 0.00% | – |
| Q1 2023 | $538 | -28.6% | 101,192 | -15.7% | 0.00% | – |
| Q4 2022 | $754 | -99.9% | 120,091 | +44.0% | 0.00% | -100.0% |
| Q3 2022 | $880,000 | +5766.7% | 83,401 | +2978.7% | 0.00% | – |
| Q2 2022 | $15,000 | -80.5% | 2,709 | -67.6% | 0.00% | – |
| Q1 2022 | $77,000 | – | 8,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
| Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
| PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
| CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
| Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
| Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
| Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
| Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |